Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $307.7000 (-1.53%) ($307.7000 - $315.7900) on Tue. May. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.11% (three month average) | RSI | 39 | Latest Price | $307.7000(-1.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -1.055% in a week (0% probabilities). VXX(-11%) TLT(-6%) IFRA(-6%) TIP(-1%) IGOV(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.055% (StdDev 2.11%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
Resistance Level | $318.6 | 5 Day Moving Average | $312.99(-1.69%) | 10 Day Moving Average | $309.26(-0.5%) | 20 Day Moving Average | $318.6(-3.42%) | To recent high | -30% | To recent low | 1.7% | Market Cap | $32.625b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |